IP Library Granted Patent US 8,039,637
Granted Patent B2
US 8,039,637 · App. 11/993,745 · Granted Oct 18, 2011

Process for preparing benzimidazole compounds

Assignee: Array BioPharma Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,039,637
App. No.
11/993,745
Granted
Oct 18, 2011
Kind
B2
Abstract

Provided are methods for the synthesis of heterocyclic compounds such as benzimidazole carboxylic acid core structures having Formula Ia-1 and their synthetic intermediates: wherein Z, X 1 , X 2 , X 5 , R 2 and R 10 are as defined herein. Compounds of Formula Ia-1 and their synthetic intermediates can be used to prepare heterocyclic derivatives such as benzimidazole derivatives.

Claims (67)

1. A process for preparing a compound of Formula Ia-1

and salts and solvates thereof, wherein:

Z is —C(═O)OR 1 , —C(═O)NR 6 R 7 , CN, —C(═O)H, or

or a moiety that can be transformed into any one of said Z groups;

R 1 is hydrogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 3 -C 10 cycloalkyl, C 3 -C 10 cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl, heterocyclylalkyl, trialkylsilyl or dialkylarylsilyl, wherein said alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl and heterocyclylalkyl portions are optionally substituted with one or more groups independently selected from halogen, hydroxyl, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl and C 3 -C 6 heterocycloalkyl;

R 2 is hydrogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, arylalkyl, trialkylsilyl, dialkylarylsilyl, —COR 6 , —C(O)OR 6 or —C(O)NR 6 R 7 , wherein said alkyl, alkenyl, alkynyl or arylalkyl portions are optionally substituted with one or more groups independently selected from halogen, hydroxyl, C 1 -C 4 alkyl, C 2 -C 4 alkenyl and C 2 -C 4 alkynyl;

X 1 and X 2 are independently selected from hydrogen, F, Cl, Br, I, OR 8 , C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 3 -C 10 cycloalkyl, C 3 -C 10 cycloalkylalkyl and C 1 -C 10 thioalkyl, wherein said alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl and thioalkyl portions are optionally substituted with one or more groups independently selected from oxo, halogen, cyano, nitro, azido, trifluoromethyl, difluoromethoxy and trifluoromethoxy;

X 5 is H, F, Cl, Br, I or C 1 -C 6 alkyl;

R 6 and R 7 are independently hydrogen, trifluoromethyl, —OR 8 , C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 3 -C 10 cycloalkyl, C 3 -C 10 cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl,

or R 6 and R 7 together with the atom to which they are attached form a 4 to 10 membered heteroaryl or heterocyclic ring, wherein said heteroaryl and heterocyclic rings are optionally substituted with one or more groups independently selected from halogen, trifluoromethyl, difluoromethoxy, trifluoromethoxy and OR 8 ;

R 8 is hydrogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, aryl or arylalkyl, wherein said alkyl, alkenyl, aryl and arylalkyl are optionally substituted with one or more groups independently selected from OH, —O—(C 1 -C 10 -alkyl) and O—(C 1 -C 10 -alkenyl);

R 10 is C 1 -C 10 alkyl, C 3 -C 10 cycloalkylalkyl, arylalkyl, heteroarylalkyl or heterocyclylalkyl, wherein said alkyl, cycloalkylalkyl, arylalkyl, heteroarylalkyl and heterocyclylalkyl portions are optionally substituted with one or more groups independently selected from halogen, hydroxyl, cyano, nitro, azido, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 heterocycloalkyl, —NR 6 R 7 and —OR 8 ; and

R 12a and R 12b are independently selected from hydrogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 3 -C 10 cycloalkyl, C 3 -C 10 cycloalkylalkyl, aryl, arylalkyl, heteroaryl and heteroarylalkyl,

or R 12a and R 12b together with the atom to which they are attached form a 4 to 10 membered carbocyclic, heteroaryl or heterocyclic ring;

said method comprising:

nitrating a compound having the Formula

wherein X 3 and X 4 are independently F, Cl, Br, I, or a sulfonate ester, to provide a compound of Formula II

treating said compound of Formula II optionally at elevated temperatures and/or pressure with two or more equivalents of (i) a reagent that contains or generates ammonia, (ii) a primary or secondary amine other than an aromatic amine or (iii) a reagent that delivers a group that can subsequently be converted into an amine to provide a compound of Formula VI-11 wherein A is —NR 2 R 2a , or treating said compound of Formula II with (iv) two or more equivalents of a metal azide optionally at elevated temperatures and/or pressure to provide a compound of Formula VI-12 wherein A is N 3

wherein R 2a is hydrogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, benzyl, allyl, arylalkyl, trialkylsilyl, dialkylarylsilyl, —COR 6 , —C(O)OR 6 , —C(O)NR 6 R 7 , —OR 1 , or —NHR 1 , wherein said alkyl, alkenyl, alkynyl, benzyl, allyl and arylalkyl portions are optionally substituted with one or more groups independently selected from halogen, hydroxyl, C 1 -C 4 alkyl, C 2 -C 4 alkenyl and C 2 -C 4 alkynyl;

reducing said compound of Formula VI-11 or VI-12 to provide a compound of Formula VIIa-1

wherein when A of Formula VI-11 or VI-12 is —NH-benzyl, —NHOR 1 or —NHNHR 1 or N 3 , then R 2 and R 2a of Formula VIIa-1 are hydrogen;

when R 2a of Formula VIIa-1 is hydrogen, cyclizing said compound of Formula VIIa-1 to provide a compound of Formula VIIIa-1

when R 2a of Formula VIIIa-1 is hydrogen, coupling said compound of Formula VIIIa-1 with a reagent having the Formula

wherein X 6 is F, Cl, Br, I, —OSO 2 CF 3 , alkyl sulfonate, aryl sulfonate, alkylaryl sulfonate, —B(OR 8 ) 2 , —BF 3 or —Bi(R 1 ) 2 , optionally either (i) at elevated temperature and optionally in the presence of a base, or (ii) in the presence of a metal-based catalyst and a base, to provide said compound of Formula Ia-1.

2. The process of claim 1 , further comprising:

reacting said compound of Formula VI-11 or VI-12 with a compound having the formula R 1 OH, optionally in the presence of an activating agent that activates the Z group towards reaction with said compound of formula R 1 OH, to provide a compound of Formula Va-11 wherein A is —NR 2 R 2a or a compound of Formula Va-12 wherein A is N 3

reducing said compound of Formula Va-11 or Va-12 to provide said compound of Formula VIIa-1 wherein Z is —COOR 1 ;

when R 2a of Formula VIIa-1 is hydrogen, cyclizing said compound of Formula VIIa-1 to provide said compound of Formula VIIIa-1 wherein Z is —COOR 1 ; and

coupling said compound of Formula VIIIa-1 with said reagent having the Formula

optionally either (i) at elevated temperature and optionally in the presence of a base, or (ii) in the presence of a metal-based catalyst and a base, to provide said compound of Formula Ia-1 wherein Z is COOR 1 .

3. The process of claim 1 , wherein said cyclization comprises

(a) reacting said compound of Formula VIIa-1, wherein R 2a is hydrogen and R 2 is not hydrogen, with (i) formic acid, optionally in the presence of an additional acid, (ii) a formic acid derivative in the presence of an acid, or (iii) formaldehyde or a formaldehyde derivative in the presence of an acid, to provide a compound of Formula XIa-1

(b) alkylating said compound of Formula XIa-1 with a reagent having the formula R 10 —Y wherein Y is Cl, Br, I, or a sulfonate ester, to provide a compound of Formula XIIa-1

(c) removing said R 2 group from the N-1 position to provide said compound of Formula VIIIa-1.

4. The process of claim 1 , wherein said cyclization comprises treating said compound of Formula VIIa-1, wherein R 2 and R 2a are H, with two or more equivalents of formaldehyde or a formaldehyde derivative in the presence of an acid to provide said compound of Formula VIIIa-1 wherein R 10 is methyl.

5. The process of claim 1 , wherein said cyclization comprises:

(a) reacting said compound of Formula VIIa-1, wherein R 2 and R 2a are hydrogen, with an acylating agent to provide a compound of Formula IXa

wherein R 10a is H, C 1 -C 10 alkyl, C 3 -C 10 cycloalkylalkyl, arylalkyl, heteroarylalkyl or heterocyclylalkyl, wherein said alkyl, cycloalkylalkyl, arylalkyl, heteroarylalkyl and heterocyclylalkyl portions are optionally substituted with one or more groups independently selected from halogen, hydroxyl, cyano, nitro, azido, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 heterocycloalkyl, —NR 6 R 7 and —OR 8 ;

(b) reducing the amide group of said compound of Formula IXa to provide a compound of Formula Xa

(c) reacting said compound of Formula Xa with (i) formic acid optionally in the presence of an additional acid or (ii) a formic acid derivative in the presence of an acid to provide said compound of Formula VIIIa-1.

6. The process of claim 1 , wherein said cyclization comprises:

(a) reacting said compound of Formula VIIa-1, wherein R 2a is hydrogen and R 2 is not hydrogen, with an acylating agent to provide a compound of Formula IXa

wherein R 10a is H, C 1 -C 10 alkyl, C 3 -C 10 cycloalkylalkyl, arylalkyl, heteroarylalkyl or heterocyclylalkyl, wherein said alkyl, cycloalkylalkyl, arylalkyl, heteroarylalkyl and heterocyclylalkyl portions are optionally substituted with one or more groups independently selected from halogen, hydroxyl, cyano, nitro, azido, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 heterocycloalkyl, —NR 6 R 7 and —OR 8 ;

(b) reducing the amide group of said compound of Formula IXa to provide a compound of Formula Xa

(c) reacting said compound of Formula Xa with (i) formic acid optionally in the presence of an additional acid or (ii) a formic acid derivative in the presence of an acid to provide a compound of Formula XIIa-1

(d) removing the R 2 group from the N-1 position to provide said compound of Formula VIIIa-1.

7. A process for preparing a compound of Formula Ia-1

and salts and solvates thereof, wherein:

Z is —C(═O)OR 1 ;

R 1 is C 1 -C 10 alkyl;

R 2 is hydrogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, arylalkyl, trialkylsilyl, dialkylarylsilyl, —COR 6 , —C(O)OR 6 or —C(O)NR 6 R 7 , wherein said alkyl, alkenyl, alkynyl or arylalkyl portions are optionally substituted with one or more groups independently selected from halogen, hydroxyl, C 1 -C 4 alkyl, C 2 -C 4 alkenyl and C 2 -C 4 alkynyl;

X 1 and X 2 are independently selected from hydrogen, F, Cl, Br, I, OR 8 , C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 3 -C 10 cycloalkyl, C 3 -C 10 cycloalkylalkyl and C 1 -C 10 thioalkyl, wherein said alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl and thioalkyl portions are optionally substituted with one or more groups independently selected from oxo, halogen, cyano, nitro, azido, trifluoromethyl, difluoromethoxy and trifluoromethoxy;

X 5 is H, F, Cl, Br, I or C 1 -C 6 alkyl;

R 6 and R 7 are independently hydrogen, trifluoromethyl, —OR 8 , C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 3 -C 10 cycloalkyl, C 3 -C 10 cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl,

or R 6 and R 7 together with the atom to which they are attached form a 4 to 10 membered heteroaryl or heterocyclic ring, wherein said heteroaryl and heterocyclic rings are optionally substituted with one or more groups independently selected from halogen, trifluoromethyl, difluoromethoxy, trifluoromethoxy and OR 8 ;

R 8 is hydrogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, aryl or arylalkyl, wherein said alkyl, alkenyl, aryl and arylalkyl are optionally substituted with one or more groups independently selected from OH, —O—(C 1 -C 10 -alkyl) and O—(C 1 -C 10 -alkenyl); and

R 10 is C 1 -C 10 alkyl, C 3 -C 10 cycloalkylalkyl, arylalkyl, heteroarylalkyl or heterocyclylalkyl, wherein said alkyl, cycloalkylalkyl, arylalkyl, heteroarylalkyl and heterocyclylalkyl portions are optionally substituted with one or more groups independently selected from halogen, hydroxyl, cyano, nitro, azido, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 heterocycloalkyl, —NR 6 R 7 and —OR 8 ;

said method comprising:

i) nitrating a compound having the Formula

wherein X 3 and X 4 are independently F, Cl, Br, I, or a sulfonate ester to provide a compound of Formula II

ii) reacting the compound of Formula II with a compound of formula R 1 OH, to form the corresponding ester having the formula

iii) reacting the ester with two or more equivalents of a reagent that generates ammonia to form a compound of Formula VI-11

wherein R 2a is hydrogen;

iv) reducing said compound of Formula VI-11 to provide a compound of Formula VIIa-1

v) cyclizing said compound of Formula VIIa-1 to provide a compound of Formula VIIIa-1

vi) coupling said compound of Formula VIIIa-1 with a reagent having the Formula

wherein X 6 is F, Cl, Br, I, —OSO 2 CF 3 , alkyl sulfonate, aryl sulfonate, alkylaryl sulfonate, —B(OR 8 ) 2 , —BF 3 or —Bi(R 1 ) 2 to provide said compound of Formula Ia-1.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2025
From: ASTRAZENECA AB
To: ALEXION PHARMA INTERNATIONAL OPERATIONS LIMITED
Reel/Frame 072888/0633 →
Continuity (2)
Provisional Application 60693270 · Jun 23, 2005
Related Publication 20100145065A1 · Jun 10, 2010